Iron overload in myelodysplastic syndromes.: Role of iron chelators

被引：1

作者：

Hernández, AA ^{[1
]}

机构：

[1] Hosp Esperit Sant, Hematol Serv, Barcelona 08923, Spain

来源：

MEDICINA CLINICA | 2005年 / 124卷 / 17期

关键词：

D O I：

10.1157/13074741

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：654 / 655

页数：2

共 14 条

[1]

[Anonymous], 2001, Tumours of the Haematopoietic and Lymphoid Tissues

[2]

BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x

[3] Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes [J].

Bowen, D ;

Culligan, D ;

Jowitt, S ;

Kelsey, S ;

Mufti, G ;

Oscier, D ;

Parker, J .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (02) :187-200

[4] Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload [J].

Franchini, M ;

Gandini, G ;

de Gironcoli, M ;

Vassanelli, A ;

Borgna-Pignatti, C ;

Aprili, G .

BLOOD, 2000, 95 (09) :2776-2779

[5]

González FA, 2005, MED CLIN-BARCELONA, V124, P645

[6]

Greenberg, 1998, BLOOD, V91, P1100

[7] International scoring system for evaluating prognosis in myelodysplastic syndromes [J].

Greenberg, P ;

Cox, C ;

LeBeau, MM ;

Fenaux, P ;

Morel, P ;

Sanz, G ;

Sanz, M ;

Vallespi, T ;

Hamblin, T ;

Oscier, D ;

Ohyashiki, K ;

Toyama, K ;

Aul, C ;

Mufti, G ;

Bennett, J .

BLOOD, 1997, 89 (06) :2079-2088

[8] Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model [J].

HellstromLindberg, E ;

Negrin, R ;

Stein, R ;

Krantz, S ;

Lindberg, G ;

Vardiman, J ;

Ost, A ;

Greenberg, P .

BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) :344-351

[9] The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload [J].

Jensen, PD ;

Heickendorff, L ;

Pedersen, B ;

BendixHansen, K ;

Jensen, FT ;

Christensen, T ;

Boesen, AM ;

Ellegaard, J .

BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (02) :288-299

[10] Long-term treatment of transfusional iron overload with the oral iron chelator deferiprone (L1): A Dutch multicenter trial [J].

Kersten, MJ ;

Lange, R ;

Smeets, MEP ;

Vreugdenhil, G ;

Roozendaal, KJ ;

Lameijer, W ;

Goudsmit, R .

ANNALS OF HEMATOLOGY, 1996, 73 (05) :247-252

← 1 2 →